2,504 results found

On June 27, 2024, the International Swaps and Derivates Association (ISDA) published a new interactive digital framework (the "ISDA Close-Out Framework") that market participants can use to help prepare for potential terminations of collateralized derivatives contracts documented under the 2002 ISDA Master Agreement.

On February 25, 2026, the Office of the Comptroller of the Currency (OCC) announced that it would issue a Notice of Proposed Rulemaking related to payment stablecoins

The President will sign H.R. 2872, a new short-term CR, extending funding to March 1 and March 8 and keeping the original "laddered" approach of two tranches of bills.

As readers of this newsletter know, the federal government has shut down after Congress failed to enact a funding...

The Department of Energy has issued a request for information on implementing President Trump's Bulk-Power System Executive Order, which would prohibit imports and installation of certain foreign-produced electric equipment deemed a national security risk. The RFI seeks public input on critical implementation questions including equipment scope, foreign entity definitions, supply chain risk assessment, and how to address already-installed equipment. Comments are due October 9, 2026, providing stakeholders a

Connecticut USAO successfully argues for an eight-year sentence for false claims of a defendant's safety supplies and cleaning services post-COVID...

This year has seen a wave of proposed bills in state legislatures across the United States, all aimed at regulating foreign-influenced political activity at the state level.

Senate leaders navigate a complex legislative landscape as they work to pass a short-term continuing resolution to fund the government through December, while simultaneously confronting debates over hemp-derived THC regulations, budget reconciliation strategies, and an unprecedented impeachment effort against OMB Director Russ Vought. The political maneuvering intensifies as Congress prepares for its August recess, with appropriators already anticipating challenging negotiations when they return in Septembe

As Congress enters its October recess and shifts into campaign mode, a growing fight over executive spending authority is complicating year-end funding negotiations. The Trump Administration's repeated testing of congressional control over federal funding has prompted bipartisan pushback from appropriators, raising the prospect of new guardrails in future appropriations bills to protect grant-making processes and prevent pocket rescissions.

In a recent case, the United States District Court for the District of Hawaii, applying Hawaii state law, granted Nautilus Insurance Company’s motion for summary judgment on its complaint for declaratory judgment and held that Nautilus did not have a duty to defend or indemnify defendant 3Builders, Inc. for alleged damages flowing from the faulty installation.

With strict page limits in AIA post-grant proceedings making it difficult for parties to fully explain their arguments, parties are often required to economize their words.

On May 30, 2011, the Internet Corporation for Assigned Names and Numbers (ICANN) released an updated version of the Applicant Guidebook (AGB) for its upcoming new generic top-level domain (gTLD) program.

Following the submission of over 1,900 applications for new generic top-level domains (gTLDs) in 2012, ICANN has been proceeding with the new gTLD evaluation process.

The Trump administration has confronted the demands of superpower status in its recent strikes against Houthi rebel targets, whose aggression in the Gulf and Levant have inflamed ongoing conflicts and whose attacks against commercial ships ...

On May 30, 2013, the US Treasury Department, Office of Foreign Assets Control issued General License D under the Iranian Transactions and Sanctions Regulations.

On January 12, 2012, the Treasury Department’s Office of Foreign Assets Control ("OFAC") published a final rule promulgating the Transnational Criminal Organizations Sanctions Regulations ("TCOSR").

On October 3, 2011, SciClone Pharmaceutical, Inc. ("SciClone"), a California specialty pharmaceutical company with substantial commercial business in China, entered into a stipulation of settlement in connection with several consolidated derivative lawsuits pending against certain members of its staff of current and former directors and officers.